Zacks Investment Research downgraded Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM) to Strong Sell in a statement released earlier today.
- Updated: September 29, 2016
Zacks Investment Research has downgraded Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM) to Strong Sell in a statement released on 9/30/2016.
Boasting a price of $26.38, Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM) traded -2.66% lower on the day. With the last stock price close up 13.02% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Sociedad Quimica y Minera de Chile (ADR) has recorded a 50-day average of $25.77 and a two hundred day average of $23.34. Volume of trade was down over the average, with 462,404 shares of SQM changing hands under the typical 549,858
With a total market value of $0, Sociedad Quimica y Minera de Chile (ADR) has price-earnings ratio of 33.52 with a one year low of $14.19 and a one year high of $28.26 .
Brief Synopsis About Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM)
Sociedad Quimica y Minera de Chile S.A. (SQM), is a producer of potassium nitrate and iodine. The Company produces specialty plant nutrients, iodine derivatives, lithium and its derivatives, potassium chloride, potassium sulfate and certain industrial chemicals. Its segments include specialty plant nutrients, industrial chemicals, iodine and derivatives, lithium and derivatives, potassium, and other products and services. Specialty plant nutrients are fertilizers that enable farmers to improve yields and the quality of certain crops. Industrial chemicals have a range of applications in chemical processes, such as the manufacturing of glass and industrial nitrates. Iodine and its derivatives are used in the X-ray contrast media and biocides industries, among others. Lithium and its derivatives are used in batteries, greases and frits for production of ceramics. Potassium chloride is a commodity fertilizer that is produced and sold by the Company across the world.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.